Please assess the completion status of the following clinical trial:

Trial Title: Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
General Inclusion Criteria:~* The patient's legal representatives must have given their informed and signed consent~* The patient must be insured or beneficiary of a health insurance plan~* Sexual maturation of at least Tanner stage 2~Inclusion criteria for the patient population~* The subject has a body mass index corresponding to grade 2 obesity according to the curves described by Rolland-Cachera et al (1991)~* Absence of at least 5% of total weight over the last 3 months~Inclusion criteria for the control population~* The subject has a body mass index \< 90th percentile~Exclusion Criteria:~* The patient is participating in another study~* The patient is in an exclusion period determined by a previous study~* The patient is under judicial protection~* The patient's legal representative(s) refuse(s) to sign the consent~* It is impossible to correctly inform the patient or his/her legal representative(s)~* The patient has a contraindication for physical activity (joint, heart or other)~* The subject does at least 3 hours of extracurricular physical activity per week~* The subject has a concomitant illness, a history of first-degree cardiovascular disease, abnormal glucose tolerance (pre-diabetes or diabetes).~* Active smoking~* Known dyslipidemia (particularly hypercholesterolemia).~* The subject regularly takes food and vitamin supplements and refuses to stop taking these during the study (in case of disruption of these supplements, a wash-out stopping period of 3 weeks is required).~* BMI corresponding to a grade 1 obesity according to the Rolland-Cachera et al. (1991) curves.~* Secondary or known genetic obesity.~* Known hypersensitivity to vitamin D.~* Hypercalcemia, hypercalciuria, calcium lithiasis

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Non-Obese group (Type: OTHER): Non-obese patients will be recruited and frequency matched to obese groups according to sex and level of sexual maturation.~Intervention: Normal control
- Obese group, Vitamin D (Type: EXPERIMENTAL): Subjects randomized to this group will receive vitamin D supplementation. They are recruited from the St Pierre Institute at Palavas-les-Flots, France.~Intervention: 3 months lifestyle and dietary management Intervention: Vitamin D supplementation
- Obese group, placebo (Type: PLACEBO_COMPARATOR): Subjects randomized to this group will receive a placebo supplement. They are recruited from the St Pierre Institute at Palavas-les-Flots, France.~Intervention: 3 months lifestyle and dietary management Intervention: Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).